Navkar Life Saver & Surgicals

3 Month15 Days Pack
750 mcg Teriparatide injection is a recombinant form of parathyroid hormone used primarily in the treatment of osteoporosis in postmenopausal women and men at high risk of fractures. Teriparatide stimulates bone formation by promoting the activity of osteoblasts, the cells responsible for building bone, thereby increasing bone mineral density and strength. This injection is typically administered subcutaneously once daily for a prescribed duration. Teriparatide is particularly effective for patients with a history of fractures or those unable to tolerate other osteoporosis treatments. Regular monitoring of calcium levels and bone density is essential during therapy to manage potential side effects, including hypercalcemia.

• Non-small cell lung cancer
• Breast cancer
• Pancreatic cancer
• Urinary bladder cancer
• Ovarian cancer

Normal Immunoglobulin Injection is a sterile solution containing immunoglobulins (antibodies) derived from human plasma. It is used to provide passive immunity by supplying the body with antibodies that help protect against infections. This injection is commonly administered to individuals with weakened immune systems, those who have been exposed to certain infections, or individuals who need immune support due to specific medical conditions.
Key Uses:

Primary Immunodeficiency: Provides essential antibodies for individuals with compromised immune systems.

Infectious Disease Prevention: Helps protect against infections in individuals exposed to certain viruses, such as hepatitis or measles.

Immune Support: Assists individuals who cannot produce sufficient antibodies on their own due to medical conditions or treatments.

Filgrastim 300 mcg Injection is a medication used to stimulate the production of white blood cells in the body. It is a form of recombinant human granulocyte colony-stimulating factor (G-CSF), which is a protein that helps the bone marrow produce neutrophils, a type of white blood cell essential for fighting infections. Filgrastim is often prescribed to patients with low white blood cell counts due to cancer treatments, bone marrow transplants, or certain other medical conditions.

• Chemotherapy-Induced Neutropenia: Helps reduce the risk of infection in patients undergoing chemotherapy by increasing neutrophil counts.
• Bone Marrow Transplant: Aids in the recovery of neutrophil counts after bone marrow transplantation.
• Severe Chronic Neutropenia: Used in individuals with chronic low white blood cell counts to reduce the frequency of infections.
• Peripheral Blood Stem Cell Mobilization: Assists in mobilizing stem cells for collection and subsequent autologous or allogeneic stem cell transplantation.

• The dosage of Filgrastim varies based on the patient’s weight and medical condition.
• It is usually administered as a subcutaneous (under the skin) injection or, in some cases, as an intravenous (IV) injection.
• Filgrastim is typically given daily until the neutrophil count reaches a desired level, which is determined by blood tests.

• Regular blood tests are required to monitor white blood cell counts and to adjust dosage as necessary.
• Caution is needed in patients with a history of sickle cell disease, as Filgrastim can potentially trigger a sickle cell crisis.
• Patients should inform their healthcare provider about any history of bone, joint, or muscle pain, as these are common side effects.

• Common side effects include bone pain, muscle pain, fatigue, and headache.
• Serious but rare side effects can include splenic rupture (pain in the left upper abdomen), acute respiratory distress syndrome (ARDS), and severe allergic reactions. Immediate medical attention is needed if symptoms of these conditions occur.

• Filgrastim should be used with caution in patients receiving chemotherapy or radiation therapy, as the timing and type of these treatments can impact Filgrastim’s effectiveness and safety.

Carboplatin is used in the treatment of ovarian cancer and small cell lung cancer. It shows its working by stopping or slowing down the growth of cancer cells.

May Treat: Ovarian cancer · Small cell lung cancer

Bevacizumab 400mg Injection is an anticancer medication used to treat various types of cancers, including colorectal, lung, and kidney cancers. It works by inhibiting vascular endothelial growth factor (VEGF), thereby preventing the growth of blood vessels that supply tumors. This helps slow tumor growth and spread.

100 mL Human Albumin Injection is a sterile solution of human albumin, a protein that is naturally found in blood plasma. This injection is used to treat a variety of conditions where there is a need to restore or maintain blood volume, such as shock, burns, surgery, and liver disease. It is also used in patients with low albumin levels due to conditions like nephrotic syndrome or chronic liver disease.

• Volume Expansion: Used to restore blood volume in cases of severe blood or plasma loss.
• Hypoalbuminemia: Treats low albumin levels, which may result from liver disease, kidney disease, or malnutrition.
• Severe Burns: Helps manage fluid balance in patients with extensive burns.
• Shock: Stabilizes blood pressure and volume in patients experiencing shock due to trauma, surgery, or infection.

• Contains Human Albumin (typically 5% or 20% concentration depending on formulation).
• May also contain small amounts of sodium and other electrolytes to match plasma osmolarity.

• Administered intravenously, usually in a hospital setting.
• Dosage and rate of administration depend on the patient’s condition, albumin level, and clinical response.

• Not recommended for patients with severe anemia, heart failure, or known hypersensitivity to albumin products.
• Caution is required in patients with dehydration or those prone to fluid overload, as it may exacerbate these conditions.
• Monitoring of blood pressure, electrolyte levels, and fluid balance is necessary during treatment.

• Possible side effects include fever, chills, rash, or flushing. Rarely, it may cause allergic reactions or fluid overload.
• Immediate medical attention is required if symptoms of an allergic reaction, such as difficulty breathing or swelling, occur.

100 mL Human Albumin Injection should be used under the supervision of a healthcare provider, as it requires careful monitoring to avoid complications. It is often part of a comprehensive treatment plan tailored to the individual patient’s needs.

11.25 mg Triptorelin powder for injection is a synthetic gonadotropin-releasing hormone (GnRH) analog used primarily in the treatment of hormone-sensitive conditions, including prostate cancer and endometriosis. Triptorelin works by initially stimulating the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), leading to a temporary increase in testosterone or estrogen levels. However, with continued use, it suppresses these hormones, effectively reducing tumor size or alleviating symptoms associated with hormone-driven diseases. The powder is reconstituted with a suitable diluent and administered via intramuscular injection. Monitoring hormone levels and patient response is essential to manage potential side effects, such as hot flashes or injection site reactions.

300 mg Bevacizumab injection is a monoclonal antibody used in cancer treatment, specifically targeting vascular endothelial growth factor (VEGF). By inhibiting VEGF, Bevacizumab prevents the formation of new blood vessels (angiogenesis) that tumors need to grow and spread. It is commonly used in the treatment of various cancers, including colorectal, lung, breast, and renal cancers, often in combination with chemotherapy. The injection is administered intravenously under the supervision of a healthcare professional, typically every two to three weeks. Regular monitoring is essential to manage potential side effects, such as hypertension, bleeding, and gastrointestinal perforations, ensuring effective and safe treatment.

440 mg Trastuzumab injection is a monoclonal antibody used in the treatment of HER2-positive breast cancer and gastric cancer. Trastuzumab specifically targets the human epidermal growth factor receptor 2 (HER2), a protein that promotes cancer cell growth when overexpressed. By binding to HER2, this injection inhibits the proliferation of tumor cells, enhances immune response against cancer cells, and may improve patient outcomes. Administered intravenously, it is typically given in combination with chemotherapy. Regular monitoring is essential to manage potential side effects, including infusion reactions, cardiotoxicity, and hypersensitivity, ensuring optimal safety and efficacy throughout the treatment regimen.